Evidence map›Paper›PMID 34302903›Full record

ArticleJournal of the American Academy of Dermatology2021

Time of onset and duration of post-COVID-19 acute telogen effluvium.

Tatiana F Abrantes, Kimberly A Artounian, Ryan Falsey, João Carlos L Simão, Sergio Vañó-Galván, Sineida B Ferreira, Tracy L Davis, Wendy Ridenour, Andy Goren, Antonella Tosti and 1 more

Abstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Post-COVID-19 Syndrome Mechanisms, Prevention and Management.International journal of preventive medicine · 2023
    Review
  14. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.Journal of family medicine and primary care · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Tatiana F AbrantesDepartment of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island.
Kimberly A ArtounianUniversity of Arizona College of Medicine, Phoenix, Arizona.
Ryan FalseyUniversity of Arizona College of Medicine, Phoenix, Arizona; East Valley Dermatology Center, Chandler, Arizona.
João Carlos L SimãoDivision of Dermatology, Department of Internal Medicine, Hospital das Clinicas University of São Paulo, Ribeirão Preto, Brazil.
Sergio Vañó-GalvánDermatology Service, Ramón y Cajal Hospital, Madrid, Spain; Instituto Ramon y Cajal de Investigación Sanitaria, Madrid, Spain; Departamento de Medicina y Especialidades Médicas, Universidad de Alcalá, Madrid, Spain.
Sineida B FerreiraClínica Dermatologia Dra. Sineida Berbert Ferreira, Maringá, Brazil.
Tracy L DavisUniversity of Arizona College of Medicine, Phoenix, Arizona; Dermpath Diagnostics, Tucson, Arizona.
Wendy RidenourEast Valley Dermatology Center, Chandler, Arizona.
Andy GorenApplied Biology, Inc, Irvine, California.
Antonella TostiDepartment of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
Carlos Gustavo WambierDepartment of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address: carlos_wambier@brown.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAlopecia AreataCOVID-19FemaleHumansInterleukin-6MalePrognosisSARS-CoV-2Time FactorsIL6 protein, humanInterleukin-6androgenetic alopeciaCOVID-19hair lossIL-6recoverySARS-COV-2telogen effluvium

Identifiers

PMID34302903
PMCPMC8294706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.